β-Lactam Resistance in Upper Respiratory Tract Pathogens Isolated from a Tertiary Hospital in Malaysia

Soo Tein Ngoi1, Anis Najwa Muhamad1, Cindy Shuan Ju Teh1

  • 1Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia.

Insights

Antimicrobial resistance is rising in respiratory pathogens. While some bacteria show high resistance to certain beta-lactams, newer agents like cefcapene remain effective against common upper respiratory tract infection (URTI) strains.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Antimicrobial resistance (AMR) in respiratory pathogens poses a significant global public health threat.
  • Common upper respiratory tract infections (URTIs) are caused by bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus.

Purpose of the Study:

  • To investigate the trends and resistance mechanisms of beta-lactam antibiotics against URTI pathogens.
  • To assess the susceptibility patterns of key respiratory pathogens in Kuala Lumpur, Malaysia.

Main Methods:

  • Analysis of 150 URTI bacterial strains isolated from a tertiary care hospital.
  • Phenotypic susceptibility testing for various beta-lactam antibiotics.
  • Molecular analysis of resistance mechanisms, including PBP mutations and beta-lactamase detection.

Main Results:

  • Streptococcus pneumoniae exhibited high non-susceptibility to penicillin G, amoxicillin-clavulanate, imipenem, and meropenem, linked to PBP mutations.
  • Haemophilus influenzae showed high susceptibility, with ampicillin resistance associated with PBP3 mutations and blaTEM presence.
  • Methicillin-susceptible Staphylococcus aureus (MSSA) strains were largely resistant to penicillin G.
  • Cefcapene and flomoxef demonstrated high efficacy against nearly all tested URTI strains.

Conclusions:

  • Beta-lactam antibiotics, excluding penicillins, generally maintain effectiveness against URTI pathogens in the studied region.
  • Understanding resistance trends and mechanisms is crucial for guiding appropriate antimicrobial therapy for URTIs.